Paracoccidioidomycosis: The dimension of the problem of a neglected disease;Paracoccidioidomicose: A dimensão do problema de uma doença negligenciada

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 43, Issue 4, 2010, Pages 480-

  Martinez, Roberto ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT;

BRAZIL; DRUG INDICATION; HEALTH CARE COST; HEALTH CARE DELIVERY; HUMAN; LETTER; MORTALITY; PARACOCCIDIOIDES BRASILIENSIS; PREVALENCE; PUBLIC HEALTH PROBLEM; PUBLICATION; SOUTH AMERICAN BLASTOMYCOSIS;

EID: 77957984802     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0037-86822010000400034     Document Type: Letter

References (11)

1. Shikanai-Yasuda MA, Telles Filho FQ, Mendes RP, Colombo AL, Moretti ML. Consenso em paracoccidioidomicose. Rev Soc Bras Med Trop 2006; 39:297-310.
2. Hotez PJ, Bottazzi ME, Franco-Paredes C, Ault SK, Periago MR. The neglected tropical diseases of Latin America and the Caribbean: a review of disease burden and distribution and a road map for control and elimination. PLoS Negl Trop Dis 2008; 2(9):e300.
3. Liese B, Rosenberg M, Schratz A. Programmes, partnerships, and governance for elimination and control of neglected tropical diseases. Lancet 2010; 375:67-76.
4. Wanke B, Londero AT. Epidemiology and paracoccidioidomycosis infection. In: Franco M, Lacaz CS, Restrepo-Moreno A, Del Negro G, editors. Paracoccidioidomycosis. Boca Raton: CRC Press; 1994. p. 109-120.
5. Paniago AMM, Aguiar JIA, Aguiar ES, Cunha RV, Pereira GR, Londero AT, et al. Paracoccidioidomicose: estudo clínico e epidemiológico de 422 casos observados no Estado de Mato Grosso do Sul. Rev Soc Bras Med Trop 2003; 36:455-459.
6. Valle ACF, Wanke B, Wanke NCF, Peixoto TC, Perez M. Tratamento da paracoccidioidomicose: estudo retrospectivo de 500 casos. I. Análise clínica, laboratorial e epidemiológica. An Bras Dermatol 1992; 67:251-254.
7. Morejón KML, Machado AA, Martinez R. Paracoccidioidomycosis in patients infected with and not infected with human immunodeficiency virus: a case-control study. Am J Trop Med Hyg 2009; 80:359-366.
8. Del Negro G. Tratamento da paracoccidioidomicose. Rev Ass Med Bras 1974; 20:231-234.
9. Pereira RM, Bucaretchi F, Barison EM, Hessel G, Tresoldi AT. Paracoccidioidomycosis in children: clinical presentation, follow-up and outcome. Rev Inst Med Trop São Paulo 2004; 46:127-131.
10. Coutinho ZF, da Silva D, Lazéra M, Petri V, Oliveira RM, Sabroza PC, et al. Paracoccidioidomycosis mortality in Brazil (1980-1995). Cad Saude Publica 2002; 18:1441-1454.
11. Prado M, Silva MB, Laurenti R, Travassos LR, Taborda CP. Mortality due to systemic mycoses as a primary cause of death or in association with AIDS in Brazil: a review from 1996 to 2006. Mem Inst Oswaldo Cruz 2009; 104:513-521.